L1CAM and ovarian carcinoma: Likewise, Drapkin and the group have shown that L1CAM contributes to the ability of transformed FT secretory cells to detach from the tube and contribute to ovarian cancer pathogenesis by upregulating fibronectin and integrin in malignant cells, and activating AKT and ERK pathways [89].